About Linus Biotechnology
Linus Biotechnology is a company based in New York (United States) founded in 2020 by Paul Curtin and Christine Austin.. Linus Biotechnology has raised $47.65 million across 4 funding rounds from investors including Yac, GreatPoint Ventures and BowX Acquisition Corp. Linus Biotechnology operates in a competitive market with competitors including Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others.
- Headquarter New York, United States
- Founders Paul Curtin, Christine Austin
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$47.65 M (USD)
in 4 rounds
-
Latest Funding Round
$6.15 M (USD), Series A
Jul 29, 2024
-
Investors
Yac
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Linus Biotechnology
Linus Biotechnology has successfully raised a total of $47.65M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $6.15 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $6.1M
-
First Round
First Round
(21 Mar 2022)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2024 | Amount | Series A - Linus Biotechnology | Valuation |
investors |
|
| May, 2023 | Amount | Series A - Linus Biotechnology | Valuation |
investors |
|
| Jan, 2023 | Amount | Series A - Linus Biotechnology | Valuation | GreatPoint Ventures , Bow Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Linus Biotechnology
Linus Biotechnology has secured backing from 5 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Yac, GreatPoint Ventures and BowX Acquisition Corp. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on early-stage big data, health tech, AI, food tech, and multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm linking startups to University of California networks.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Linus Biotechnology
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Linus Biotechnology
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Linus Biotechnology Comparisons
Competitors of Linus Biotechnology
Linus Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Genomics, Depixus, Seven Bridges Genomics, Ingenuity Systems and BC Platforms, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Genomic risk assessment and prevention platform is provided.
|
|
| domain | founded_year | HQ Location |
Single-molecule genetic and epigenetic sequencing solutions are provided.
|
|
| domain | founded_year | HQ Location |
Cloud-based platform to analyze, store, and act on genomic data.
|
|
| domain | founded_year | HQ Location |
Genomic data is analyzed and interpreted via web-based applications.
|
|
| domain | founded_year | HQ Location |
Platforms for genomic data analysis and management are provided.
|
|
| domain | founded_year | HQ Location |
Machine learning is utilized for precision medicine and genetic diagnostics.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Linus Biotechnology
Frequently Asked Questions about Linus Biotechnology
When was Linus Biotechnology founded?
Linus Biotechnology was founded in 2020 and raised its 1st funding round 2 years after it was founded.
Where is Linus Biotechnology located?
Linus Biotechnology is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Linus Biotechnology a funded company?
Linus Biotechnology is a funded company, having raised a total of $47.65M across 4 funding rounds to date. The company's 1st funding round was a Series A of $16M, raised on Mar 21, 2022.
What does Linus Biotechnology do?
Developer of diagnostic tests for central nervous system and gastrointestinal disorders. The company offers StrandDx ASD, a non-invasive diagnostic aid for Autism Spectrum Disorder. The companys pipeline comprises precision exposome medicine biomarkers and target discovery across gastroenterology, renal disease and oncology.
Who are the top competitors of Linus Biotechnology?
Linus Biotechnology's top competitors include Depixus, Ingenuity Systems and Envisagenics.
Who are Linus Biotechnology's investors?
Linus Biotechnology has 5 investors. Key investors include Yac, GreatPoint Ventures, BowX Acquisition Corp, Divergent Investments, and Nicole Shanahan.